AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 87 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $27,000 | -74.3% | 10,900 | -28.8% | 0.00% | – |
| Q1 2022 | $105,000 | +9.4% | 15,300 | +44.3% | 0.00% | – |
| Q1 2021 | $96,000 | -45.5% | 10,600 | -59.7% | 0.00% | -100.0% |
| Q4 2020 | $176,000 | -22.8% | 26,300 | -41.9% | 0.00% | 0.0% |
| Q3 2020 | $228,000 | -27.8% | 45,300 | +15.9% | 0.00% | -50.0% |
| Q2 2020 | $316,000 | -78.7% | 39,100 | -79.1% | 0.00% | -81.8% |
| Q1 2020 | $1,486,000 | +230.2% | 187,200 | +213.8% | 0.01% | +266.7% |
| Q4 2019 | $450,000 | +248.8% | 59,654 | +91.9% | 0.00% | +200.0% |
| Q3 2019 | $129,000 | +892.3% | 31,078 | +935.9% | 0.00% | – |
| Q3 2018 | $13,000 | -96.1% | 3,000 | -90.6% | 0.00% | -100.0% |
| Q3 2017 | $336,000 | +5.3% | 32,000 | +10.7% | 0.00% | 0.0% |
| Q2 2017 | $319,000 | +398.4% | 28,900 | +337.9% | 0.00% | – |
| Q1 2017 | $64,000 | – | 6,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,673,718 | $20,949,000 | 10.15% |
| Vivo Capital, LLC | 3,575,424 | $28,389,000 | 2.57% |
| COWEN AND COMPANY, LLC | 1,517,296 | $10,767,000 | 2.47% |
| VR Adviser, LLC | 1,057,827 | $8,399,000 | 2.28% |
| RTW INVESTMENTS, LP | 4,616,570 | $36,253,000 | 1.56% |
| GENDELL JEFFREY L | 553,516 | $4,395,000 | 1.35% |
| Avoro Capital Advisors LLC | 4,365,655 | $34,663,000 | 1.17% |
| Arlington Capital Management, Inc. | 115,902 | $920,000 | 0.85% |
| Ghost Tree Capital, LLC | 350,000 | $2,779,000 | 0.74% |
| PURA VIDA INVESTMENTS, LLC | 496,660 | $3,943,000 | 0.47% |